Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,472.00
Bid: 12,492.00
Ask: 12,496.00
Change: 74.00 (0.60%)
Spread: 4.00 (0.032%)
Open: 12,432.00
High: 12,526.00
Low: 12,318.00
Prev. Close: 12,398.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: S&P CapIQ Cuts Next To Buy From Strong Buy

Tue, 05th Jan 2016 09:43

LONDON (Alliance News) - The following shares received analyst recommendations Tuesday morning:
----------
FTSE 100
----------
S&P CAPITAL IQ CUTS NEXT TO 'BUY' ('STRONG BUY') - TARGET 85 (91) PENCE
----------
CREDIT SUISSE RAISES BUNZL PRICE TARGET TO 1780 (1660) PENCE - 'NEUTRAL'
----------
CREDIT SUISSE RAISES TRAVIS PERKINS TO 'OUTPERFORM' ('NEUTRAL') - TARGET 2255 (1838) PENCE
----------
Deutsche Bank Upgrades Tesco To Buy From Hold Ups Price Target To 210p From 200p
----------
JPMORGAN RAISES HIKMA PRICE TARGET TO 2700 (2500) PENCE - OVERWEIGHT
----------
JPMORGAN RAISES GLAXOSMITHKLINE PRICE TARGET TO 1390 (1370) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES ASTRAZENECA PRICE TARGET TO 4500 (4400) PENCE - 'NEUTRAL'
----------
Cantor Fitzgerald Raises Royal Mail To Buy From Hold Ups Price Target To 530p From 500p
----------
BARCLAYS CUTS ABERDEEN AM TO UNDERWEIGHT (EQUAL WEIGHT) - TARGET 250 (350) PENCE
----------
SOCGEN CUTS MARKS & SPENCER PRICE TARGET TO 595 (652) PENCE - 'BUY'
----------
JPMORGAN RAISES SMITH & NEPHEW PRICE TARGET TO 1089 (1024) PENCE - 'NEUTRAL'
----------
FTSE 250
----------
MORGAN STANLEY CUTS SSP GROUP TO 'UNDERWEIGHT' ('EQUAL-WEIGHT')
----------
HSBC INITIATES JLT GROUP WITH 'BUY' - TARGET 1020 PENCE
----------
JPMORGAN CUTS ROTORK PRICE TARGET TO 170 (180) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS HALFORDS GROUP PRICE TARGET TO 380 (460) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES BODYCOTE PRICE TARGET TO 510 (500) PENCE - 'UNDERWEIGHT'
----------
JPMORGAN CUTS BTG TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 780 (900) PENCE
----------
GOLDMAN CUTS MELROSE INDUSTRIES PRICE TARGET TO 360 (380) PENCE - 'BUY'
----------
BARCLAYS RAISES LANCASHIRE HOLDINGS PRICE TARGET TO 428 (419) PENCE - UNDERWEIGHT
----------
BARCLAYS RAISES HISCOX PRICE TARGET TO 684 (645) PENCE - 'UNDERWEIGHT'
----------
GOLDMAN CUTS WEIR GROUP PRICE TARGET TO 1500 (1550) PENCE - 'BUY'
----------
GOLDMAN CUTS SPECTRIS PRICE TARGET TO 2130 (2200) PENCE - 'BUY'
----------
Deutsche Upgrades Morrisons To Hold From Sell, Price Target 155p
----------
MAIN MARKET AND AIM
----------
JPMORGAN CUTS OXFORD INSTRUMENTS PRICE TARGET TO 870 (950) PENCE - 'OVERWEIGHT'
----------
GOLDMAN CUTS OXFORD INSTRUMENTS PRICE TARGET TO 685 (700) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES SPIRE HEALTHCARE PRICE TARGET TO 395 (310) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES CAMBIAN PRICE TARGET TO 278 (222) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES ABCAM PRICE TARGET TO 606 (558) PENCE - 'NEUTRAL'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 09:41

LONDON BROKER RATINGS: Deutsche Bank starts Deliveroo at 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
12 Feb 2024 09:12

Barclays sees "compelling" entry point at AstraZeneca after recent falls

(Sharecast News) - Barclays has kept an 'overweight' position on AstraZeneca despite the biopharma group's disappointing annual results last week, saying that the stock's recent underperformance provides an attractive entry point for investors.

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
9 Feb 2024 07:51

LONDON BRIEFING: Barclays buys Tesco's retail banking business

(Alliance News) - Stocks in London are called to open higher on Friday, closing off a busy corporate week.

Read more
8 Feb 2024 17:00

LONDON MARKET CLOSE: Softer earnings weigh on underperforming FTSE 100

(Alliance News) - London's FTSE 100 ended lower on Thursday, with mixed corporate updates keeping a lid on enthusiasm, while in New York the S&P 500 has the 5,000 point mark in touching distance.

Read more
8 Feb 2024 14:42

London close: Stocks slip as US jobless claims fall

(Sharecast News) - London markets experienced a downturn in trading on Thursday, with stocks relinquishing earlier gains as investors processed a decrease in jobless claims in the United States.

Read more
8 Feb 2024 12:08

LONDON MARKET MIDDAY: DS Smith surges on takeover approach from Mondi

(Alliance News) - Stock prices in London were mixed at midday Thursday, as markets struggled to find direction amid a mixed wave of corporate updates and earnings.

Read more
8 Feb 2024 08:59

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.

Read more
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.